During the past decade, Bon Secours Liver Institute of Virginia - Richmond conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bon Secours Liver Institute of Virginia - Richmond" are "Cirrhosis" (1 trials), "NASH - Nonalcoholic Steatohepatitis" (1 trials), "Nonalcoholic Steatohepatitis (NASH) With Fibrosis" (1 trials) and "Prevention of Esophageal Varices" (1 trials). Many other conditions were trialed in "Bon Secours Liver Institute of Virginia - Richmond" in a lesser frequency.

Most popular intervention types in "Bon Secours Liver Institute of Virginia - Richmond" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Elafibranor" (1 trials) and "belapectin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bon Secours Liver Institute of Virginia - Richmond" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Bon Secours Liver Institute of Virginia - Richmond". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Bon Secours Liver Institute of Virginia - Richmond, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Bon Secours Liver Institute of Virginia - Richmond, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".